Sunesis Pharmaceuticals - Inspired to Make a Difference in Cancer Patients Lives.

SNS-510 Program Presentations

Download a presentation for more information.
Adobe® Reader®

PDK1 inhibitors SNS-229 and SNS-510 cause pathway modulation, apoptosis and tumor regression in hematologic cancer models in addition to solid tumors
Boston, MA
Sunday, November 8, 2015
Download (PDF,582KB)